Aclaris Therapeutics

Entity > Corporation > US > New York City New York > Aclaris Therapeutics

About Aclaris Therapeutics

Aclaris Therapeutics, Inc. is a pharmaceutical company that deals in identifying, developing, and commercialization of drugs and therapies to meet needs in dermatology, medical, and immunology sectors. Aclaris Therapeutics serves patients in the United States.

KINect® is Aclaris Therapeutics’ Proprietary Drug Discovery Platform: Aclaris Therapeutics, Inc. has a multi-stage portfolio of drug candidates based on KINect®. The Company's drug candidates are Zunsemetinib (ATI -450), ATI -1777 and ATI -2138. ATI -450 is an orally administered, selective small molecule MK2 inhibitor for the treatment of rheumatoid arthritis. ATI -1777, a topical JAK 1/3 inhibitor for the treatment of atopic dermatitis. It is also developing ATI -2138 as a potential treatment for T cell-mediated autoimmune diseases. The company is also developing oral inhibitors of intestinal flora JAK as a potential treatment for inflammatory bowel disease.

Aclaris Operates in Two Segments: Aclaris Therapeutics, Inc. operates in two segments: Therapeutics and Contract Research. The Therapeutics segment is engaged in identifying and developing innovative therapies to address significant unmet needs in immune-inflammatory diseases. The Contract Research segment is active in the provision of laboratory services.

Aclaris Therapeutics, Inc. Was Founded in 2012: The company was incorporated in 2012 and is headquartered in Wayne, Pennsylvania.

Industry: Business & Industrial > Pharmaceuticals & Biotech

More information about Aclaris Therapeutics

Company Attribute Value
Address StreetAddress: 640 Lee Rd Ste 200, AddressLocality: Wayne, AddressRegion: Pennsylvania, PostalCode: 19087, AddressCountry: United States
Founding Date 2012
Name Aclaris Therapeutics
Number Of Employees 72
Revenue $6,437,000 USD
Ticker Symbol NASDAQ: ACRS
Url aclaristx
Facebook facebook
Linkedin linkedin
Twitter twitter
Google google
Wikidata wikidata

Aclaris Therapeutics

us

New York City, US
5 Feb 2024

New York City, US
5 Feb 2024

Aclaris Therapeutics

All
News
Images
Maps
Videos
More
Page: 1 Desktop | Laptop Devices

https://www.aclaristx.com/
Home | Aclaris Therapeutics Inc.
https://finance.yahoo.com › quote › ACRS
Aclaris Therapeutics, Inc. (ACRS) Stock Price, News, Quote ...
https://www.reuters.com › healthcare-pharmaceuticals › a...
Aclaris shares plummet on terminating development of ...
https://www.linkedin.com/company/aclaris-therapeutics-inc-
Aclaris Therapeutics, Inc.
https://www.fiercebiotech.com › biotech › aclaris-lays-...
Aclaris lays off 46%, resurrects zunsemetinib for cancer
https://www.cnbc.com › quotes › ACRS
ACRS: Aclaris Therapeutics Inc - Stock Price, Quote and ...
https://www.drugs.com › manufacturer › aclaris-thera...
Aclaris Therapeutics, Inc. Company Information
Related Searches
Related Searches
Aclaris therapeutics news
aclaris therapeutics pipeline
aclaris therapeutics products
Google My Business
Google My Business

Aclaris Therapeutics, Inc (Pharmaceutical company in Chesterbrook, Pennsylvania)

aclaristx.com/
  • Located in : Chesterbrook Corporate Center
  • Address : 701 Lee Rd #103, Wayne, PA 19087
  • Phone : (484) 324-7933
Google My Business
Google My Business

Aclaris Therapeutics (Pharmaceutical company)

aclaristx.com/

Aclaris Therapeutics, Inc. is a clinical-stage biopharmaceutical company developing a pipeline of novel drug candidates to address the needs of patients with immuno-inflammatory diseases who lack satisfactory treatment options.

linkedin.com/company/aclaris-therapeutics-inc-#:~:text=Aclaris%20Therapeutics%2C%20Inc.%20is%20a,who%20lack%20satisfactory%20treatment%20options.
  • Located in : Chesterbrook Corporate Center
  • Address : 701 Lee Rd #103, Wayne, PA 19087
  • Phone : (484) 324-7933
  • Stock price : ACRS (NASDAQ) $1.19 -0.03 (-2.07%)Feb 5, 11:23 AM EST - Disclaimer
  • Founded : 2012
  • Headquarters : Pennsylvania

All information on this page is taken from publicly available sources, and the analysis we provide is a representation of Google's search results for the entity and does not represent any opinion or judgement about the entity by Kalicube itself. If you disagree with this analysis, please contact us and cite this reference : 188914